Prospective Assessment of Efficacy and Safety of Drug Eluting Stents

CompletedOBSERVATIONAL

Enrollment

6,023

Participants

Timeline

Start Date

December 31, 2013

Primary Completion Date

July 31, 2015

Study Completion Date

July 31, 2015

Conditions

Coronary Heart Disease

Trial Locations (1)

Fuwai hospital, Beijing

All Listed Sponsors

lead

China National Center for Cardiovascular Diseases

OTHER_GOV

NCT02313038 - Prospective Assessment of Efficacy and Safety of Drug Eluting Stents | Biotech Hunter | Biotech Hunter